• News
  • SAN DIEGO
  • Finance

Halozyme climbs as analyst upgrades stock

Shares of Halozyme Therapeutics Inc. jumped Monday after a BMO Capital Markets analyst upgraded the stock, saying he expects it to do better in 2013.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!